<DOC>
	<DOC>NCT00293917</DOC>
	<brief_summary>A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis</brief_summary>
	<brief_title>A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis</brief_title>
	<detailed_description>A long-term, open label, non-comparative, multi-center study to evaluate the safety of tacrolimus cream-B 0.1% in treating the signs and symptoms of psoriasis.</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Clinical diagnosis of plaque psoriasis Skin disorder other than plaque psoriasis in the areas to be treated. Disease on only scalp</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Treatment Outcome</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Safety</keyword>
	<keyword>Psoriasis</keyword>
</DOC>